Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Chronic Airflow Obstruction Compared to Chronic Obstructive Pulmonary Disease Patients without Bronchiectasis.
Yeonseok ChoiSun Hye ShinHyun Jee LeeHyun Kyu ChoYunjoo ImNoeul KangHye Sook ChoiHye Yoon ParkPublished in: International journal of chronic obstructive pulmonary disease (2021)
Bronchiectasis patients with CAO could benefit more from long-term azithromycin treatment than COPD patients without bronchiectasis.